Smithkline Beecham) Pharmaceuticals (India) Limited v. CIT
111 Taxmann 561Supreme Court of India2000#4403 most cited
What is Smithkline Beecham) Pharmaceuticals (India) Limited v. CIT authority for?
Expenditure incurred by pharmaceutical companies in distributing free samples to doctors is considered publicity and sales promotion, and therefore, it is not disallowable under Section 37(1) of the Income-tax Act.
27
judgments rely on this decision, according to BharatTax’s citation analysis of 292,668 Indian tax judgments — from 2015 to 2021.
Also referred to as
Smithkline Beecham Pharmaceuticals India Limited v CIT · Eskayef Pharmaceuticals v CIT · 245 ITR 116 · Section 37(1) · free samples · doctors · publicity · sales promotion · pharmaceutical companies · disallowable expenditure
Also reported as
245 ITR 116
Judgments citing Smithkline Beecham) Pharmaceuticals (India) Limited v. CIT
Showing 1–20 of 27 · Page 1 of 2